Exocure Therapeutics Overview
ExoCure Therapeutics develops exosome-based cancer therapeutics designed to selectively target tumor pathways while reducing harm to healthy cells.
Latest News
No news articles.
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
0
Web & Social Links
| Website | exocure-therapeutics.com/ |
Locations
9 Al-Rihana, Sakhnin, Israel
אלריחאנה, Sakhnin, 3081000, Israel
Photos & Videos
No files yet
Exocure Therapeutics Business
Business models
—
Product stage
R&D
Employees
—
Sector
—Target Customer
—Core Technology
—Exocure Therapeutics Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
Exocure Therapeutics Lifecycle
Exocure Therapeutics News
0 articlesNo news articles.
Exocure Therapeutics Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Exocure Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 37/100 |
| Missing | sector, number of employees, tags, invite member, business model, logo, description, video or image, funding rounds, news, markets, external profiles, not claimed |
| Registrar ID | 517213088 |
| Creator | Ofir Muchnik |
| Creator email | ofirm@sncentral.org |
| Last update | 2026-03-15T00:00:00.000Z |
| Created | 2026-03-15T00:00:00.000Z |